Literature DB >> 11672911

BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens.

M L Garly1, C Balé, C L Martins, M A Baldé, K L Hedegaard, H C Whittle, P Aaby.   

Abstract

To examine risk factors for anergy, delayed-type hypersensitivity was assessed among 884 infants participating in a vaccine trial in Guinea-Bissau. The infants were skin-tested at 7.5 months of age with a panel of seven intradermal antigens. Risk factors for anergy to tuberculin or anergy to both the diphtheria and tetanus antigens were determined in relation to Bacillus Calmette-Guérin (BCG) vaccination, diphtheria-tetanus-pertussis (DTP) vaccination, and measles vaccination. We found sick children to be more anergic to tuberculin and diphtheria-tetanus antigens than healthy children (OR=2.49 (95% confidence interval 1.40-4.55)). There was a higher prevalence of anergy to tuberculin in the rainy season than in the dry season (OR=1.67 (1.25-2.23)). Children who had taken antimalarials within the last week had a higher prevalence of anergy to tuberculin (OR=1.41 (1.02-1.92)). BCG vaccination was significantly associated with less anergy to tuberculin and diphtheria-tetanus antigens (OR=0.42 (0.28-0.63), OR=0.77 (0.60-0.99), respectively). Children vaccinated with BCG before 1 month of age were more anergic to tuberculin than children vaccinated after 1 month (OR=1.61 (1.19-2.19)). DTP vaccination was associated with less anergy to diphtheria-tetanus antigens (OR=0.40 (0.32-0.49)), but not to tuberculin. Children with a positive reaction to tuberculin were less likely to be anergic to diphtheria-tetanus antigens (OR=0.36 (0.26-0.49)) than children with a negative tuberculin reaction. Children who were vaccinated with BCG before they received their last DTP vaccine were less anergic to diphtheria-tetanus antigens (OR=0.40 (0.16-0.88)) than other DTP-vaccinated children. In conclusion, current disease, rainy season, age below 1 month of age at the time of BCG vaccination, and administration of chloroquine or quinimax within the last 7 days were risk factors for anergy to tuberculin among 7.5-month-old infants. BCG vaccination and a positive tuberculin reaction were associated with a lower prevalence of anergy to both tuberculin and diphtheria-tetanus. Thus, BCG vaccination may contribute to better cell-mediated immune responses among infants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672911     DOI: 10.1016/s0264-410x(01)00339-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Authors:  C Sander; H McShane
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

2.  Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment.

Authors:  Erliyani Sartono; Ida M Lisse; Elisabeth M Terveer; Paula J M van de Sande; Hilton Whittle; Ane B Fisker; Adam Roth; Peter Aaby; Maria Yazdanbakhsh; Christine S Benn
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

3.  Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

Authors:  Peter Aaby; Christine Benn; Jens Nielsen; Ida Maria Lisse; Amabelia Rodrigues; Henrik Ravn
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692

4.  Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.

Authors:  Sarah Prentice; Emily L Webb; Hazel M Dockrell; Pontiano Kaleebu; Alison M Elliott; Stephen Cose
Journal:  Trials       Date:  2015-04-11       Impact factor: 2.279

5.  The burden of presumed tuberculosis in hospitalized children in a resource-limited setting in Papua New Guinea: a prospective observational study.

Authors:  Villa Watch; Jimmy Aipit; Tina Kote-Yarong; Allanie Rero; John W Bolnga; Elvin Lufele; Moses Laman
Journal:  Int Health       Date:  2017-11-01       Impact factor: 2.473

6.  Scar formation and tuberculin conversion following BCG vaccination in infants: A prospective cohort study.

Authors:  Sara S Dhanawade; Suhas G Kumbhar; Alka D Gore; Vijay N Patil
Journal:  J Family Med Prim Care       Date:  2015 Jul-Sep

7.  Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau.

Authors:  Kristoffer Jarlov Jensen; Sofie Biering-Sørensen; Johan Ursing; Poul-Erik Lund Kofoed; Peter Aaby; Christine Stabell Benn
Journal:  BMJ Glob Health       Date:  2020-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.